Schering-Plough Gets Japanese Temodal Approval
Posted on: Tuesday, 1 August 2006, 21:00 CDT
The Japan Ministry of Health, Labor and Welfare has approved Schering-Plough's Temodal capsules for the treatment of malignant glioma.
The approval follows a priority review of the company's new drug application submission, which was granted in September 2005 to satisfy an unmet medical need in Japanese patients. Temodal (temozolomide), marketed as Temodar in the US, is approved in 77 countries.
In Japan, Temodal is indicated for both treatment-naive newly-diagnosed patients (in combination with radiotherapy), and previously treated patients with malignant gliomas.
The Japanese Ministry of Health, Labor and Welfare (MHLW) approval is based on efficacy and safety data from six studies including a study of 32 Japanese patients with recurrent anaplastic astrocytoma, and a phase III study conducted by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC).
The phase III study involved 573 patients with newly diagnosed glioblastoma multiforme and demonstrated longer survival in the patients who received Temodal and radiation compared with those who received only radiation.
Temodal will become available upon determination of pricing by the MHLW. It will be available in 20mg and 100mg capsule strengths.
Source: Datamonitor
Related Articles
- Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies With REOLYSIN(R)
- Semafore and Multiple Myeloma Research Consortium (MMRC) Dose First Patient in Phase I Study of Targeted PI3 Kinase (PI3K) Inhibitor
- St. Paul Heart Clinic Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- ValueOptions and Colorado Health Networks Win Administrative Services Only Contract; Social Security Administration's Mental Health Treatment Study Contract Awarded to Westat With ValueOptions and Colorado Health Networks Serving As ASO
- St. Francis Hospital Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Newark Beth Israel Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Drugs equivalent in angina treatment: study
- California Pacific Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Patients With Treatment-Resistant Schizophrenia Get Good News Today at American Psychiatric Association Meeting in Atlanta
- U. Enlists Patients in Clinical Study Linked to Fatal Lung Disease
 |
 |
User Comments (0)
RSS Feeds